Making Science Group, S.A.

MSE:MAKS.MC

9 (EUR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22023 Q12022 Q42022 Q22021 Q22020 Q42020 Q2
Revenue 121.857113.90958.021112.53197.60145.59834.44223.229
Cost of Revenue 102.755108.53253.108105.71590.03239.86132.04921.77
Gross Profit 19.1025.3774.9136.8177.5695.7372.3931.458
Gross Profit Ratio 0.1570.0470.0850.0610.0780.1260.0690.063
Reseach & Development Expenses 000.22900000
General & Administrative Expenses 00000000
Selling & Marketing Expenses 00000000
SG&A 7.8587.4383.7197.2657.5422.7991.507-0.04
Other Expenses 0.208-0.2142.1470.1670.205-1.4240.344-0.228
Operating Expenses 7.657.6526.0957.0987.3364.2231.1630.188
Operating Income 11.452-2.275-1.182-0.2810.2331.5141.231.27
Operating Income Ratio 0.094-0.02-0.02-0.0020.0020.0330.0360.055
Total Other Income Expenses Net -9.719-2.049-0.977-1.727-1.268-1.514-0.365-0.062
Income Before Tax 1.733-4.325-2.159-2.008-1.03500.8661.208
Income Before Tax Ratio 0.014-0.038-0.037-0.018-0.01100.0250.052
Income Tax Expense 1.0330.1990.11.350.16900.2730.259
Net Income 0.749-4.55-2.275-3.467-1.51800.5930.949
Net Income Ratio 0.006-0.04-0.039-0.031-0.01600.0170.041
EPS 0.09-0.55-0.27-0.42-0.1700.0860.14
EPS Diluted 0.09-0.55-0.27-0.42-0.1700.0860.14
EBITDA 11.9861.9830.3373.8413.6961.5141.7451.639
EBITDA Ratio 0.0980.0170.0060.0340.0380.0330.0510.071